BCHE and Alzheimer disease: There are currently only six FDA-approved therapies to treat Alzheimer’s disease (AD): cholinesterase inhibitors (donepezil, galantamine, and rivastigmine), an n-methyl-D-aspartate receptor antagonist (memantine), and two anti-amyloid antibodies (aducanumab and lecanemab) [1–3].